Teva Pharmaceutical, Owner of Frazer's Cephalon, Forms Joint Venture With Japanese Drug Firm
Teva Pharma appoints Novartis, Biogen vet as new president and CEO – PharmaLive
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva Pharmaceutical Industries Ltd. | Facebook
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block | Fierce Pharma
Teva has made short work of its hunt for a new CEO
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Announces New Organization Structure and Leadership Changes - Pharma Advancement
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Teva Pharmaceutical Industries Limited Executive Team | Comparably
Teva makes changes to North American leadership, other executive management roles | ROI-NJ
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Eli Shani - EVP, Global Marketing & Portfolio at Teva Pharmaceutical Industries | The Org
Teva Pharmaceuticals Office Photos | Glassdoor
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals Executive Team | Comparably
Teva Appoints John Nason President, TAPI and Biologics Operations | Business Wire
Teva Pharmaceuticals Executive Team | Comparably
Teva Announces Changes to Executive Management Team | Business Wire
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
